Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 616 AL 630

Parkinson's disease as a result of aging

Rodriguez M, Rodriguez-Sabate C, Morales I, Sanchez A, Sabate M.

Aging Cell. 2015 Jun;14(3):293-308. doi: 10.1111/acel.12312. Epub 2015 Feb 9.

Working on asymmetry in Parkinson's disease: randomized, controlled pilot study

Ricciardi L, Ricciardi D, Lena F, Plotnik M, Petracca M, Barricella S, Bentivoglio AR, Modugno N, Bernabei R, Fasano A.

Neurol Sci. 2015 Aug;36(8):1337-43. doi: 10.1007/s10072-015-2082-8. Epub 2015 Feb 13.

Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?

Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, Martinez J, Tijero B, Berganzo K, Kaufmann H.

Mov Disord. 2015 Apr 15;30(5):639-45. doi: 10.1002/mds.26079. Epub 2015 Feb 12.

Monoamine oxidase: radiotracer chemistry and human studies

Fowler JS, Logan J, Shumay E, Alia-Klein N, Wang GJ, Volkow ND.

J Labelled Comp Radiopharm. 2015 Mar;58(3):51-64. doi: 10.1002/jlcr.3247. Epub 2015 Feb 10.

PIPs in neurological diseases

Waugh MG.

Biochim Biophys Acta. 2015 Aug;1851(8):1066-82. doi: 10.1016/j.bbalip.2015.02.002. Epub 2015 Feb 11.

Neuroproteomics tools in clinical practice

Shevchenko G, Konzer A, Musunuri S, Bergquist J.

Biochim Biophys Acta. 2015 Jul;1854(7):705-17. doi: 10.1016/j.bbapap.2015.01.016. Epub 2015 Feb 10.

Using Sepia melanin as a PD model to describe the binding characteristics of neuromelanin - A critical review

Schroeder RL, Double KL, Gerber JP.

J Chem Neuroanat. 2015 Mar-Apr;64-65:20-32. doi: 10.1016/j.jchemneu.2015.02.001. Epub 2015 Feb 11.

[Perioperative management of Parkinson's disease]

Shimohata T, Shimohata K, Nishizawa M.

Brain Nerve. 2015 Feb;67(2):205-11. doi: 10.11477/mf.1416200113.

Head injury and risk for Parkinson disease: results from a Danish case-control study

Kenborg L, Rugbjerg K, Lee PC, Ravnskjær L, Christensen J, Ritz B, Lassen CF.

Neurology. 2015 Mar 17;84(11):1098-103. doi: 10.1212/WNL.0000000000001362. Epub 2015 Feb 13.

Sequential movement skill in Parkinson's disease: a state-of-the-art

Ruitenberg MF, Duthoo W, Santens P, Notebaert W, Abrahamse EL.

Cortex. 2015 Apr;65:102-12. doi: 10.1016/j.cortex.2015.01.005. Epub 2015 Jan 24.

Molecular imaging of levodopa-induced dyskinesias

Niccolini F, Rocchi L, Politis M.

Cell Mol Life Sci. 2015 Jun;72(11):2107-17. doi: 10.1007/s00018-015-1854-x. Epub 2015 Feb 15.

Dreaming furiously? A sleep laboratory study on the dream content of people with Parkinson's disease and with or without rapid eye movement sleep behavior disorder

Valli K, Frauscher B, Peltomaa T, Gschliesser V, Revonsuo A, Högl B.

Sleep Med. 2015 Mar;16(3):419-27. doi: 10.1016/j.sleep.2014.10.014. Epub 2015 Jan 16.

Status of treatment for dementia patients who visited hospital as the first visit

Chang H, Park H, Lee HS, Cheong J, Kang H.

Arch Gerontol Geriatr. 2015 May-Jun;60(3):453-6. doi: 10.1016/j.archger.2015.01.018. Epub 2015 Feb 3.

The relation between α-synuclein and microglia in Parkinson's disease: Recent developments

Sanchez-Guajardo V, Tentillier N, Romero-Ramos M.

Neuroscience. 2015 Aug 27;302:47-58. doi: 10.1016/j.neuroscience.2015.02.008. Epub 2015 Feb 12.

Edible mushrooms: improving human health and promoting quality life

Valverde ME, Hernández-Pérez T, Paredes-López O.

Int J Microbiol. 2015;2015:376387. doi: 10.1155/2015/376387. Epub 2015 Jan 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias